Real-time enrollment status for this transthyretin amyloid cardiomyopathy (attr cm) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:49 AM UTC
| NCT Number | NCT07207811 |
| Recruiting Status | Recruiting |
| Condition | Transthyretin Amyloid Cardiomyopathy (ATTR CM) |
| Phase | Clinical Trial |
| Target Enrollment | 1,280 participants |
| Active Locations | 61 sites in the US |
| Sponsor | Novo Nordisk A/S |
| Last Updated on CT.gov | June 25, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT07207811 is currently recruiting participants. This clinical trial study for transthyretin amyloid cardiomyopathy (attr cm) is actively seeking new participants at 61 locations across the United States. The study is sponsored by Novo Nordisk A/S. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07207811 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 61 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07207811 was last updated 2 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.